News

Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletter

Pharmaceutical Technology\'s In the Lab eNewsletter-11-07-2018
Volume13
Issue 11

Avid Bioservices Hits Milestone in Laboratory Expansion

The company has broken ground on the construction of a new laboratory space.

Avid Bioservices, a contract development and manufacturing organization, has achieved a milestone in its ongoing expansion of its process development capabilities and laboratories, the company announced on Oct 9, 2018.

In early October 2018, the company began demolition at the site that will provide approximately an additional 3,000 ft2 of new process development laboratory space. The new space will allow for the consolidation of cell line development, upstream process development, and upstream pilot-scale production in a single location. The facility will enhance the company’s ability to deliver compliant and economically viable biologics manufacturing processes and execute technology transfer of existing processes.

The new facility will feature bioreactor development and control systems designed specifically to enable Avid to streamline projects into cGMP manufacturing and will allow for a high level of automation and reporting capabilities. It will also be compatible with evolving process control strategies, such as online metabolite and cell density sensors, process analytical technology, and bioreactor sampling devices.

The company also reported that it plans to triple the current capacity provided by its benchtop bioreactor systems. The expansion also requires the active hiring of additional process development scientists, the company said.

Source: Avid Bioservices

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content